Status:
TERMINATED
HEART Camp Connect: A Feasibility Study
Lead Sponsor:
University of Nebraska
Conditions:
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study builds on the tested and refined HEART Camp intervention which has been shown to improve long-term adherence to exercise in individuals diagnosed with heart failure. HEART Camp Connect enha...
Detailed Description
Potential participants will be approached at a Heart Failure clinic at an academic medical center. As a secondary recruitment strategy, we will use a database that identifies patients who previously i...
Eligibility Criteria
Inclusion
- Diagnosis of heart failure (HF) with an ejection fraction (EF) ≥50%
- Age ≥18 years
- English-speaking
- Echocardiogram in prior 12 months
- Stable pharmacologic therapy in past 30 days
Exclusion
- Score\<6 on a diagnostic algorithm
- Life-limiting illness precluding study completion
- Clinical evidence of decompensated HF
- Unstable angina or marked shortness of breath on exertion at \<2 metabolic equivalents
- Myocardial infarction, coronary artery bypass surgery, or biventricular pacemaker \<6 weeks
- Orthopedic or neuromuscular disorders preventing participation in aerobic exercise
- Cardiopulmonary exercise test results that preclude safe exercise
- Unwilling/unable to complete pre-randomization procedures
- Pregnancy
- Implantable cardioverter-defibrillator
Key Trial Info
Start Date :
March 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2023
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT05985395
Start Date
March 28 2022
End Date
November 20 2023
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198-5330